AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pgimet M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Taksa LIfe Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Pgimet M 1mg/500mg Tablet SR

Diabetax Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetax Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. The most frequent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with its symptoms—sweating, dizziness, headache, and tremors—and appropriate countermeasures. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Pgimet M 1mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Pgimet M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pgimet M 1mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking. Administer this extended-release tablet with a meal.

Common Side effects of Pgimet M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Pgimet M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or dividing it. The Pgimet M 1mg/500mg sustained-release tablet should be taken with a meal.

How Pgimet M 1mg/500mg Tablet SR works:

Pgimet M 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Pgimet M 1mg/500mg Tablet SR and alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Pgimet M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Pgimet M (1mg/500mg) tablets are contraindicated for breastfeeding mothers. Evidence indicates a potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Pgimet M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For individuals with severe kidney disease, Pgimet M 1mg/500mg Tablet SR is contraindicated. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Pgimet M 1mg/500mg SR tablets cautiously, as dose modification may be necessary. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Pgimet M 1mg/500mg Tablet SR :

Should you forget a dose of Pgimet M 1mg/500mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Pgimet M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Pgimet M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Pgimet M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare but dangerous side effect is particularly risky for patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Pgimet M 1mg/500mg Tablet SR and seek immediate medical attention.
Pgimet M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Pgimet M 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Pgimet M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Pgimet M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Pgimet M 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Pgimet M 1mg/500mg Tablet...
42
MRP 49
14% off